| Company Name: |
Patheon Inc. |
| Business: |
Contract pharmaceutical dosage form development and manufacturing services |
| Established: |
1974 |
| Corporate Office: |
US Headquarters
Patheon Inc.
PO Box 110145
Research Triangle Park, NC 27709-5145
Phone:919-226-3200 |
| CEO: |
Wesley P. Wheeler |
| Annual Revenues: |
US$ 655.1M (2009 Fiscal Year) |
| Fiscal Year End: |
October 31 |
| Trading Symbol: |
PTI (traded on TSX – Toronto Stock Exchange) |
| Total Employees: |
Approximately 4,000 |
| Number of Facilities: |
11 |
| Customers Served: |
Approximately 300 |
| Development Centers: |
8 |
| Development Scientists: |
Over 1000 scientists including more than 100 PHD’s |
| Projects in Development: |
300 |
Capabilities at a Glance
Patheon offers a full range of pharmaceutical development and manufacturing across its international network of facilities.
Click here to view a matrix of Patheon’s development and manufacturing capabilities.